ARDX
Price
$3.68
Change
+$0.04 (+1.10%)
Updated
Jun 6 closing price
Capitalization
868.5M
53 days until earnings call
RIGL
Price
$21.49
Change
+$0.52 (+2.48%)
Updated
Jun 6 closing price
Capitalization
374.78M
Interact to see
Advertisement

ARDX vs RIGL

Header iconARDX vs RIGL Comparison
Open Charts ARDX vs RIGLBanner chart's image
Ardelyx
Price$3.68
Change+$0.04 (+1.10%)
Volume$6.93M
Capitalization868.5M
Rigel Pharmaceuticals
Price$21.49
Change+$0.52 (+2.48%)
Volume$182.37K
Capitalization374.78M
ARDX vs RIGL Comparison Chart
Loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARDX vs. RIGL commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDX is a Buy and RIGL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (ARDX: $3.91 vs. RIGL: $19.19)
Brand notoriety: ARDX and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARDX: 57% vs. RIGL: 68%
Market capitalization -- ARDX: $868.5M vs. RIGL: $374.78M
ARDX [@Biotechnology] is valued at $868.5M. RIGL’s [@Biotechnology] market capitalization is $374.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARDX’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • ARDX’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, both ARDX and RIGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARDX’s TA Score shows that 5 TA indicator(s) are bullish while RIGL’s TA Score has 6 bullish TA indicator(s).

  • ARDX’s TA Score: 5 bullish, 4 bearish.
  • RIGL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than ARDX.

Price Growth

ARDX (@Biotechnology) experienced а -2.01% price change this week, while RIGL (@Biotechnology) price change was -8.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ARDX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARDX($868M) has a higher market cap than RIGL($375M). RIGL YTD gains are higher at: 14.090 vs. ARDX (-22.880). RIGL has higher annual earnings (EBITDA): 28.5M vs. ARDX (-16.71M). ARDX has more cash in the bank: 250M vs. RIGL (77.3M). RIGL has less debt than ARDX: RIGL (60M) vs ARDX (153M). ARDX has higher revenues than RIGL: ARDX (334M) vs RIGL (179M).
ARDXRIGLARDX / RIGL
Capitalization868M375M231%
EBITDA-16.71M28.5M-59%
Gain YTD-22.88014.090-162%
P/E RatioN/A10.03-
Revenue334M179M187%
Total Cash250M77.3M323%
Total Debt153M60M255%
FUNDAMENTALS RATINGS
ARDX vs RIGL: Fundamental Ratings
ARDX
RIGL
OUTLOOK RATING
1..100
511
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
95100
PRICE GROWTH RATING
1..100
9047
P/E GROWTH RATING
1..100
46100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RIGL's Valuation (78) in the Biotechnology industry is in the same range as ARDX (98). This means that RIGL’s stock grew similarly to ARDX’s over the last 12 months.

RIGL's Profit vs Risk Rating (93) in the Biotechnology industry is in the same range as ARDX (100). This means that RIGL’s stock grew similarly to ARDX’s over the last 12 months.

ARDX's SMR Rating (95) in the Biotechnology industry is in the same range as RIGL (100). This means that ARDX’s stock grew similarly to RIGL’s over the last 12 months.

RIGL's Price Growth Rating (47) in the Biotechnology industry is somewhat better than the same rating for ARDX (90). This means that RIGL’s stock grew somewhat faster than ARDX’s over the last 12 months.

ARDX's P/E Growth Rating (46) in the Biotechnology industry is somewhat better than the same rating for RIGL (100). This means that ARDX’s stock grew somewhat faster than RIGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARDXRIGL
RSI
ODDS (%)
Bullish Trend 11 days ago
81%
Bearish Trend 11 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
76%
Bearish Trend 11 days ago
88%
Momentum
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 11 days ago
80%
MACD
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 11 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
79%
Bearish Trend 11 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
82%
Bearish Trend 11 days ago
86%
Advances
ODDS (%)
Bullish Trend 19 days ago
86%
Bullish Trend 18 days ago
83%
Declines
ODDS (%)
Bearish Trend 17 days ago
81%
Bearish Trend 25 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
89%
Bearish Trend 11 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 11 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ARDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with HRTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then HRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDX
1D Price
Change %
ARDX100%
-1.51%
HRTX - ARDX
37%
Loosely correlated
-3.17%
RIGL - ARDX
37%
Loosely correlated
-2.19%
CSCI - ARDX
35%
Loosely correlated
+2.12%
PCVX - ARDX
34%
Loosely correlated
-1.10%
RNAC - ARDX
34%
Loosely correlated
+3.65%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been closely correlated with CLNN. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if RIGL jumps, then CLNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
-2.19%
CLNN - RIGL
92%
Closely correlated
+0.76%
DARE - RIGL
88%
Closely correlated
+2.50%
PHIO - RIGL
84%
Closely correlated
+16.96%
AZTR - RIGL
84%
Closely correlated
-3.45%
IMRN - RIGL
82%
Closely correlated
-6.22%
More